Показано 0 из 0
Дата |
---|
17.05.2024 |
16.05.2024 |
15.05.2024 |
14.05.2024 |
13.05.2024 |
10.05.2024 |
09.05.2024 |
08.05.2024 |
07.05.2024 |
06.05.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
3.20
|
3.29
|
3.21
|
3.12
|
3.26
|
3.18
|
|
|
1 015 604.63
|
2 145.00
|
3.23
|
3.28
|
3.35
|
3.22
|
3.36
|
3.22
|
|
|
783 137.56
|
1 830.00
|
3.38
|
3.45
|
3.41
|
3.35
|
3.5839
|
3.38
|
|
|
1 167 532.81
|
2 220.00
|
3.35
|
3.40
|
3.25
|
3.245
|
3.45
|
3.40
|
|
|
1 485 538.49
|
2 825.00
|
3.28
|
3.33
|
3.25
|
3.22
|
3.43
|
3.28
|
|
|
1 144 325.85
|
2 239.00
|
3.25
|
3.33
|
3.54
|
3.17
|
3.5599
|
3.25
|
|
|
1 624 243.39
|
3 097.00
|
3.43
|
3.59
|
3.45
|
3.44
|
3.57
|
3.47
|
|
|
706 839.84
|
1 671.00
|
3.44
|
3.54
|
3.52
|
3.44
|
3.55
|
3.47
|
|
|
1 037 309.65
|
1 946.00
|
3.61
|
3.68
|
3.71
|
3.595
|
3.7636
|
3.62
|
|
|
859 457.44
|
1 474.00
|
3.68
|
3.71
|
3.75
|
3.60
|
3.79
|
3.73
|
|
|
788 017.54
|
1 351.00
|
Tempest Therapeutics Inc. operates as a development-stage biotechnology company. The Company focuses on targeted and immune-eediated cancer therapies that modulate anti-tumor immunity pathways. Tempest Therapeutics serves customers worldwide.